The implosion of blood diagnostics developer Theranos has raised the question: What is feasibly detectible in a drop of blood? Emily Waltz reports.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A cartridge based Point-of-Care device for complete blood count
Scientific Reports Open Access 09 December 2019
-
A review of microsampling techniques and their social impact
Biomedical Microdevices Open Access 15 August 2019
-
The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package
European Journal of Clinical Microbiology & Infectious Diseases Open Access 02 February 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Washburn, A.L. et al. Procedia Eng. 25, 63–66 (2011).
Dittmer, W.U. et al. Clin. Chim. Acta 411, 868–873 (2010).
Choi, J. et al. Biosens. Bioelectron. 85, 1–7 (2016).
Wang, Y. et al. Biosens. Bioelectron. 70, 61–68 (2015).
Phipps, W.S. et al. J. Vis. Exp. 93, e51743 (2014).
Mor, O. et al. J. Clin. Microbiol. 53, 3458–3465 (2015).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waltz, E. After Theranos. Nat Biotechnol 35, 11–15 (2017). https://doi.org/10.1038/nbt.3761
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3761
This article is cited by
-
A cartridge based Point-of-Care device for complete blood count
Scientific Reports (2019)
-
A review of microsampling techniques and their social impact
Biomedical Microdevices (2019)
-
The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package
European Journal of Clinical Microbiology & Infectious Diseases (2019)